Forecast: Chronic Obstructive Pulmonary Diseases Mortality in Australia

Based on the data, the mortality rate for Chronic Obstructive Pulmonary Diseases (COPD) in Australia is expected to increase annually from 2024 to 2028, starting at 7.85 thousand deaths in 2024 and reaching 8.2 thousand deaths by 2028. For comparison, the actual number of deaths in 2023 stood at approximately 7.75 thousand.

Year-on-year variations indicate a steady rise in COPD mortality. The increase from 2023 to 2024 is approximately 1.29%, and from 2025 onward, there is a consistent annual growth rate of around 1.27% to 1.25%. The compound annual growth rate (CAGR) over the forecasted five-year period from 2024 to 2028 averages to 1.35%, highlighting a modest but continuous rise in COPD-related deaths.

Future trends to watch for:

  • Advancements in medical treatments and early diagnosis that may potentially reduce mortality rates.
  • Public health initiatives focusing on smoking cessation and pollution control, which could impact COPD mortality trends.
  • Demographic changes, such as an aging population, that could contribute to the increasing mortality rate.

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease